Who Paid My Doc
Dipen Maun
Colon & Rectal Surgery Mooresville, IN Medical Doctor
NPI 1154547420 CMS profile 98177
1215 Hadley Rd Ste 201, Mooresville, IN 46158
General payments
$11,622
Research payments
$273
Ownership & investment interest
$0
Research they led as principal investigator
$210,514
Through program year 2025, Dipen Maun of Mooresville, IN is reported in the CMS Open Payments database as having received $11,622 across 50 general payments and $273 in research payments paid to them. Separately, studies naming them as principal investigator received $210,514 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 80th percentile of Colon & Rectal Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $226 | 4 | |
| 2023 | General | $900 | 1 | |
| 2022 | General | $3,099 | 6 | |
| 2021 | General | $2,599 | 5 | |
| 2020 | General | $823 | 5 | |
| 2019 | General | $3,974 | 29 | |
| 2019 | Research | $273 | 4 |
Beside peers
- Dipen Maun
- Colon & Rectal Surgery median
- Middle half of Colon & Rectal Surgery
- National median
In program year 2025, general payments to Dipen Maun were reported at $226. Among 1,481 Colon & Rectal Surgery profiles paid that year, the median was $317 and the middle half received between $109 and $1,248.
Show as a table
| Year | Dipen Maun | Colon & Rectal Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $3,974 | $443 | $125–$2,179 | $163 |
| 2020 | $823 | $167 | $53–$931 | $114 |
| 2021 | $2,599 | $207 | $72–$1,272 | $132 |
| 2022 | $3,099 | $341 | $111–$1,587 | $149 |
| 2023 | $900 | $322 | $115–$1,420 | $160 |
| 2024 | $0 | $328 | $112–$1,354 | $164 |
| 2025 | $226 | $317 | $109–$1,248 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 10 drugsPart D claims
294
Drug cost
$17,139
Branded share of claims
52%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Linzess Linaclotide | Brand | 16 | $8,699 | |
| Loperamide Loperamide Hcl | Brand | 37 | $2,768 | |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | Brand | 39 | $2,228 | |
| Budesonide Dr Budesonide | Brand | 11 | $1,371 | |
| Dicyclomine Hcl | Generic | 42 | $1,247 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 38 | $487 | |
| Metronidazole | Generic | 76 | $123 | |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | Brand | 12 | $102 | |
| Hydrocortisone | Generic | 11 | $88 | |
| Ondansetron Hcl | Generic | 12 | $25 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,507 Part D prescribers listed as Colorectal Surgery (Proctology); they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 85 billing codesPaid by Medicare
$129,454
Medicare patients
354
Services billed
709
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 73% | |
| Arthritis | 45% | |
| Diabetes | 31% | |
| Ischemic heart disease | 31% | |
| Depression | 28% | |
| Cancer | 27% | |
| Chronic kidney disease | 25% | |
| COPD | 20% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
54 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Colon & Rectal Surgery in Indiana
Shekar Narayanan
Colon & Rectal Surgery · Indianapolis, IN
Imran Ahmad
Colon & Rectal Surgery · Munster, IN
Edward Delle Donne
Colon & Rectal Surgery · South Bend, IN
Joshua Wallet
Colon & Rectal Surgery · Fort Wayne, IN
Santiago Arruffat
Colon & Rectal Surgery · Evansville, IN
William Oh
Colon & Rectal Surgery · Mooresville, IN
Related records
Colon & Rectal Surgery in Indiana
Practitioners in the same specialty and state, ranked by reported value.
All Colon & Rectal Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Indiana
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.